00546 FUFENG GROUP
- 5.470
- +0.090+1.67%
FUFENG GROUP News
阜豐集團：年報 2023
Fufeng Group (00546.HK): Performance is in line with expectations, high dividends drive value revaluation
The 2023 results are in line with our expectations, and Fufeng Group announced the 2023 results: revenue of 28.01 billion yuan, +1.9% year on year; net profit to mother of 3.14 billion yuan, corresponding to earnings per share of 1.24 yuan, year-on-year.
FUFENG GROUP To Go Ex-Dividend On June 3rd, 2024 With 0.22 HKD Dividend Per Share And 0.13 HKD Special Dividend Per Share
March 29th - $FUFENG GROUP(00546.HK)$ is trading ex-dividend on June 3rd, 2024. Shareholders of record on June 4th, 2024 will receive 0.22 HKD dividend per share and 0.13 HKD special dividend per
Fufeng Group's Profit Down Nearly 19% in 2023
Fufeng Group (HKG:0546) recorded an 18.6% decline in attributable profit for the year ended Dec. 31, 2023, to 3.14 billion yuan from 3.86 billion yuan during the year-ago period, a Wednesday filing on
Fufeng Group (00546) announced annual results. Profit attributable to shareholders was about 3.1 billion yuan, a year-on-year decrease of 18.6%
Fufeng Group (00546) announced its 2023 annual results, with revenue of about 28 billion yuan (RMB, same below), same...
Fufeng Group (00546) will pay a final dividend of HK$0.22 per share on June 28
Fufeng Group (00546) announced that the company will pay a final dividend of 0 per share on June 28, 2024...
FUFENG GROUP: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
Fufeng Group (00546.HK) held a board meeting on March 27 to approve the release of annual results
Gelonghui, March 15, 丨 Fufeng Group (00546.HK) announced that the board of directors meeting will be held on March 27, 2024 (Wednesday) to approve (among other things) the publication of the annual results of the company and its subsidiaries for the year ended December 11, 2023, and consider recommending the payment of the company's final dividend (if any).
FUFENG GROUP: NOTICE OF BOARD MEETING
Changes in Hong Kong stocks | Fufeng Group (00546) rose more than 5%, institutions say the industry pattern is stable, profitability is strong, and the profits and dividends of companies are all relatively stable
Fufeng Group (00546) rose more than 5%. As of press release, it had risen 5.23% to HK$5.03, with a turnover of HK$27.5098 million.
SDIC Securities: The food and beverage industry is resilient and clearly actively recommends companies with changing competitiveness during the off-peak season
China Investment Securities believes that sector valuations are still at the bottom, excellent companies can still have excess profits, and continue to recommend the sector.
Global Glutamic Acid Market Size, Share & Trends Analysis Forecast Report to 2030, Featuring Ajinomoto, Medinex, Haihang Industry, Fufeng Group, Amino & Evonik Industries
The "Global Glutamic Acid Market Size, Share & Trends Analysis Report By End-use (Food Industry, Pharmaceutical, Cosmetic & Personal Care, and...
Fufeng Group (00546.HK) acquired Jacques Marie J. Berghmans OTC shares of 56.0939 million shares worth approximately HK$242 million
On February 8, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on February 8, Jacques Marie J. Berghmans increased its OTC share holdings of $Fufeng Group (00546.HK) by an average price of HK$4.31 per share on February 6 by $56.939 million, worth approximately HK$242 million. After the increase in holdings, Jacques Marie J. Berghmans's latest shareholding was 282 million shares, and the good position ratio rose from 8.91% to 11.10%. Additional Information: Although not exactl
Repurchase Collection on February 5 | Pharmaceutical Biotech, HSBC Holdings, etc. bought back one after another. Of these, Yao Ming Biotech cost HK$234 million
According to documents disclosed by the Hong Kong Stock Exchange on February 6, $Yao Ming Biotech (02269.HK) $ and $HSBC Holdings (00005.HK) $ repurchased shares. ① $Yao Ming Biotech (02269.HK) $ repurchased 13.493 million common shares on February 5, involving an amount of HK$234 million. The repurchase price per share ranged from HK$17.82 to HK$16.9. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) is 58.3535 million shares, accounting for 1.374% of the number of shares issued when the ordinary resolution was passed. ② $HSBC
Fufeng Group (00546.HK) spent HK$1,719,600 to buy back 410,000 shares on February 5
On February 5, Gelonghui Group (00546.HK) announced that on February 5, it spent HK$1,719,600 to buy back 410,000 shares, at a price of HK$4.22-4.17 per share.
Fufeng Group (00546.HK) spent HK$4,220 to buy back 1,000 shares on February 2
On February 5, Gelonghui Group (00546.HK) announced that on February 2, it spent HK$4,220 to repurchase 1,000 shares at a price of HK$4.22 per share.
January 31 repurchase collection | AIA, HSBC Holdings, etc. bought back one after another, of which AIA spent HK$183 million
According to documents disclosed by the Hong Kong Stock Exchange on February 1, $AIA (01299.HK) $ and $HSBC Holdings (00005.HK) $ repurchased shares. ① $AIA (01299.HK) $ repurchased 3 million common shares on January 31, involving an amount of HK$183 million. The repurchase price per share ranged from HK$62.3 to HK$60.5. The cumulative number of securities repurchased during the year (since the adoption of the ordinary resolution) was 281 million shares, accounting for 2.417% of the number of shares issued when the ordinary resolution was passed. ② $HSBC Holdings (00005
Fufeng Group (00546.HK) spent HK$1.375 million to buy back 326,000 shares on January 31
Gelonghui, January 31 | Fufeng Group (00546.HK) announced that on January 31, it spent HK$1.375,000 to repurchase 326,000 shares at a price of HK$4.22-4.18 per share.
Fufeng's Subsidiary Wins 15 Million Yuan Compensation for Production Secrecy Infringement
Fufeng Group's (HKG:0546) subsidiary, Shandong Fufeng Fermentation, won a case involving the infringement of the commercial production secrecy of Xanthan Gum after the Supreme People's Court in China
Fufeng Group (00546.HK) wins lawsuit against Xinjiang Meihua, Meihua Biotech and Zhang Wei for infringing trade secrets in xanthan gum production
Fufeng Group (00546.HK) announced that after leaving the company's wholly-owned subsidiary Shandong Fufeng Fermentation Co., Ltd. (plaintiff) against Xinjiang Meihua Amino Acid Co., Ltd. (Xinjiang Meihua), Meihua Biotechnology Group Co., Ltd.) and Zhang Wei (Xinjiang Meihua, Meihua Biotech Group Co., Ltd., and Zhang Wei are collectively the “defendant”), the plaintiff alleges that after leaving the plaintiff's office, Zhang Wei leaked the commercial production technology knowledge of xanthan gum obtained during his work at the plaintiff's office to Xinjiang Mei Mei and Mei organisms.
Analysis
Price Target
No Data
